Latest news with #AFYREN
Business Wire
08-07-2025
- Business
- Business Wire
AFYREN Receives €4 Million in Grants for AFYREN NEOXY and Starts New Performance-Driven Investment Strategy
CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering industrial customers bio-based, low-carbon products through its unique fermentation technology based on a circular model, today receives €4 million in grants for AFYREN NEOXY and starts a performance-driven investment strategy to reinforce AFYREN's forward-looking industrial model. Grant received at a pivotal moment for AFYREN NEOXY The funds granted are part of the 'France Relance' initiative by Bpifrance to support strategic investments in critical sectors. This subsidy represents the second installment of an €8 million package, of which €2 million was previously granted to AFYREN NEOXY at the launch of the program in June 2021. This new payment comes at a key moment in AFYREN NEOXY's industrial development. This one-of-a-kind biorefinery has recently entered its industrial ramp-up phase, with the goal of producing and marketing several hundred tons of products in the second half of 2025 1. The funds will be partially used to consolidate AFYREN NEOXY's current achievements by funding ongoing adjustments to the plant as part of its reliability program, plus other strategic investments to enhance the plant's performance and optimize operations. AFYREN NEOXY Optimization Strategy AFYREN has identified improvements which, with an additional investment of around €20 million, would enable the company to increase production capacity to 20 kt —a 20% increase compared to the initially planned 16 kt— and raise projected EBITDA to €14 million, representing a 40% increase over current forecasts of €9 million. To support the planned investment and the ramp-up of AFYREN NEOXY, AFYREN may draw on part of its available cash, estimated at around €27 million as of end-June 2025, while ensuring it maintains sufficient financial flexibility for operations. Other sources of financing 2 may also be mobilized, with the aim of preserving a balanced and sustainable financial structure. This optimization strategy would enable the AFYREN Group 3 to reach breakeven with its very first plant, with AFYREN's proportional share of EBITDA from the AFYREN NEOXY plant covering the holding company's annual cash consumption. Nicolas SORDET, CEO of AFYREN, declares: " This public support from the French State reinforces our forward-looking industrial model, serving both the ecological transition and economic sovereignty. It comes at a pivotal moment in AFYREN's history: after having validated our technology at industrial scale, we are now entering a phase of operational optimization and commercial acceleration. This subsidy enables AFYREN NEOXY to consolidate its achievements and initiate our investment strategy aimed at significantly enhancing the plant's performance and shortening the critical path to the Group's overall profitability." About AFYREN AFYREN is a French greentech company, founded in 2012, focused on providing innovative, sustainable solutions to reduce reliance on fossil-based resources. AFYREN's proprietary, nature-inspired fermentation technology valorizes local biomass from non-food agricultural co-products to produce 100% biobased, low-carbon carboxylic acids. The company's sustainable solutions address decarbonization challenges in a wide variety of strategic sectors, including human and animal nutrition, flavors and fragrances, life sciences, materials science, plus lubricants and technical fluids. AFYREN's competitive, plug-and-play, circular technology enables manufacturers to adopt sustainable solutions without modifying production processes. The company's first industrial plant, AFYREN NEOXY, a joint venture with Bpifrance's SPI fund, is based in the Grand-Est region of France, serving primarily the European market. AFYREN is also pursuing a project in Thailand with a global leader in the sugar industry and is building its presence in the Americas, based on existing distribution agreements. At the end of 2024, AFYREN employed 130 people across sites in Lyon, Clermont-Ferrand and Carling Saint-Avold. Committed to continuous innovation, the company invests 20% of its annual budget in R&D to further develop the range of sustainable solutions. AFYREN is listed on Euronext Growth ® Paris since 2021 (ISIN code: FR0014005AC9, ticker: ALAFY). For more information, visit and follow us on LinkedIn. Financial calendar 1 See press release dated June 17, 2025: 2 Including the portion already secured but not yet drawn down from the loans obtained in Q4 2024 and Q1 2025 (see press release dated January 8, 2025: ) and the grants already secured for the benefit of AFYREN NEOXY (final payment form the CBE-JU for AFTER-BIOCHEM and additional payment from the 'France Relance' plan) 3 Defined here as AFYREN holding company and AFYREN NEOXY based on a 51% equity interest
Yahoo
17-06-2025
- Business
- Yahoo
AFYREN Begins New Phase of Industrial Strategy as First Plant AFYREN NEOXY Achieves Continuous Production
AFYREN NEOXY: continuous production achieved and acceleration in commercialization Industrial continuous running1 of all stages of the process validated in recent weeks and start of industrial ramp-up Hundreds of tons of bio-based acids produced and currently being commercialized €165 million in revenue secured by contracts, to be executed in coming years Update on short and medium-term objectives AFYREN NEOXY: objective to achieve significant production revenue in 2025, estimated in the low single-digit million euros range2, and plant break-even3 targeted within a few quarters AFYREN: aims to achieve the goal of building and operating three plants in a sequence manner to better capitalize on the success of AFYREN NEOXY, including intermediary debottlenecking project4 CLERMONT-FERRAND, France & LYON, France, June 17, 2025--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering industrial customers bio-based, low-carbon products through its unique fermentation technology based on a circular model, today announced its first plant AFYREN NEOXY has achieved continuous production, enabling the acceleration of commercialization. Nicolas SORDET, CEO AFYREN, declares: "The transition to continuous production at AFYREN NEOXY, the first biorefinery using the AFYREN technology, demonstrates our command of all key stages of an innovative process with no equivalents worldwide. This major success marks the end of an especially demanding period for our teams, whose dedication and resilience I sincerely commend. We are now in the industrial ramp-up phase, enabling us to regularly deliver finished products to our customers in increasing volumes. Building on this success, we are planning to increase our industrial capacity production gradually in coming quarters, in order to better capitalize on AFYREN NEOXY." Continuous production achieved and acceleration in commercialization AFYREN has successfully manufactured hundreds of tons of products in recent weeks, resulting from continuous production at the plant. The bio-based acids produced are currently undergoing qualification prior to delivery, in accordance with the multi-year contracts signed with customers. This major milestone is the culmination of two years of efforts by the AFYREN and AFYREN NEOXY teams to ensure the reliability of the equipment and mastering the operating conditions at industrial scale, ensuring the continuous operation of this unique biorefinery. This milestone marks the beginning of a new phase that will see the gradual ramp-up of AFYREN NEOXY's industrial production to ultimately achieve the targets set in 2021: annual production revenue of around €35 million with a current EBITDA margin of around 25% (equivalent to a current EBITDA of around €9 million) at full capacity (16,000 tons per year). During the ramp-up period, product shipment will be made on a regular basis with priority given to long-term customers. As a reminder, commercial commitments secured through contracts represent cumulative revenue of over €165 million, to be recognized in the upcoming years. These contracts are with leading players in the target markets of human nutrition and feed, flavors and fragrances, life sciences, materials sciences, and lubricants. Update on short and medium-term objectives On this basis, AFYREN NEOXY expects production revenue in 2025 to be in the low single-digit million euros range5. The plant is expected to break even (positive current EBITDA) within a few quarters. In parallel, AFYREN is planning targeted investments to lift bottlenecks6 at the AFYREN NEOXY plant. By doing so, AFYREN would increase production capacity and boost target profitability beyond the previously mentioned objectives. AFYREN's medium-term objectives will be updated to reflect the progress of the AFYREN NEOXY ramp-up. The core operational and financial targets remain unchanged — specifically the plan to build and operate three production sites, generating a combined €150 million in revenue at full capacity7 with a target Group EBITDA margin of around 30%. Instead of adhering strictly to the current target of having three plants installed, of which two in continuous production by 2028, AFYREN is exploring a phased approach. This would allow the company to consolidate the achievements of its first biorefinery and leverage the operational experience gained before moving forward with the development of Plants 2 and 3. This approach will enable the Group to maintain a safe degree of agility and keep good control of AFYREN's cash burn and should enable the financing of future plants under optimized conditions. Stefan BORGAS, Chairman of AFYREN's Board of Directors, added: "The transition to continuous production is a major milestone in AFYREN's history. The Company is joining a very select group of companies that have successfully industrialized a competitive green technology. This is a remarkable achievement in the increasingly demanding and selective chemical industry. It opens up extremely positive prospects for our company in terms of industrial and commercial development." About AFYREN AFYREN is a French greentech company, founded in 2012, focused on providing innovative, sustainable solutions to reduce reliance on fossil-based resources. AFYREN's proprietary, nature-inspired fermentation technology valorizes local biomass from non-food agricultural co-products to produce 100% biobased, low-carbon carboxylic acids. The company's sustainable solutions address decarbonization challenges in a wide variety of strategic sectors, including human and animal nutrition, flavors and fragrances, life sciences, materials science, plus lubricants and technical fluids. AFYREN's competitive, plug-and-play, circular technology enables manufacturers to adopt sustainable solutions without modifying production processes. The company's first industrial plant, AFYREN NEOXY, a joint venture with Bpifrance's SPI fund, is based in the Grand-Est region of France, serving primarily the European market. AFYREN is also pursuing a project in Thailand with a global leader in the sugar industry and is building its presence in the Americas, based on existing distribution agreements. At the end of 2024, AFYREN employed 130 people across sites in Lyon, Clermont-Ferrand and Carling Saint-Avold. Committed to continuous innovation, the company invests 20% of its annual budget in R&D to further develop the range of sustainable solutions. AFYREN is listed on Euronext Growth® Paris since 2021 (ISIN code: FR0014005AC9, ticker: ALAFY). For more information, visit and follow us on LinkedIn. Financial calendar Events Dates Annual General Meeting Tuesday, June 17, 2025, in Lyon 2025 half-year results Thursday, September 25, 2025 1 Simultaneous operation of all stages of the process – from fermentation to finished products, in a stable and repeatable manner2 Projections subject to operational adjustments to be made to increase production rates during the ramp-up phase3 Positive current EBITDA from production4 Removal of capacity bottlenecks identified in the operations chain, enabling increased production capacity and reliability of operations with a higher target profitability for AFYREN NEOXY5 Projections subject to operational adjustments to be made to increase production rates during the ramp-up phase6 Removal of capacity bottlenecks identified in the operations chain, enabling increased production capacity and reliability of operations with a higher target profitability for AFYREN NEOXY7 After a ramp-up period View source version on Contacts AFYRENDirector for ESG, Communications and Public AffairsCaroline Investor RelationsMark Reinhardinvest@ NewCapInvestor RelationsThéo Martin / Mathilde BohinTel: +33 1 44 71 94 94afyren@ Media RelationsNicolas Mérigeau / Gaëlle FromaigeatTel: +33 1 44 71 94 98afyren@ MC Services AG (international)Investor RelationsBettina EllinghorstMedia RelationsShaun Brown, Dr. Johanna KoblerTel: +49 89 210 228 0afyren@ Sign in to access your portfolio
Yahoo
02-06-2025
- Business
- Yahoo
AFYREN: Availability of Preparatory Documents for the Combined General Meeting on June 17, 2025
E-voting available (VOTACCESS) from June 2, 2025, to June 16, 2025 (03:00 pm CEST) CLERMONT-FERRAND, France & LYON, France, June 02, 2025--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering industrial customers bio-based, low-carbon products through its unique fermentation technology based on a circular model, today announced its Combined General Meeting will be held Tuesday, June 17, 2025, at 3:30 pm CEST, at the Company's office: Le Silex2 - City, 9 rue des Cuirassiers - 69003 Lyon. The preparatory documents for this General Meeting are available on the Company's website, in the Documentation / General Meetings section. The text of the resolutions was published in the meeting notice, published in the "Bulletin des Annonces Légales Obligatoires" (BALO) No. 57 of May 12, 2025. To submit their votes, shareholders may, in accordance with the procedures described in the meeting notice published in the BALO on May 12, 2025: attend the Meeting in person; vote by internet via the secure voting platform VOTACCESS; vote by mail; give proxy to the Chairman of the Meeting or to any other person of their choice. About AFYREN AFYREN is a French greentech company, founded in 2012, focused on providing innovative, sustainable solutions to reduce reliance on fossil-based resources. AFYREN's proprietary, nature-inspired fermentation technology valorizes local biomass from non-food agricultural co-products to produce 100% biobased, low-carbon carboxylic acids. The company's sustainable solutions address decarbonization challenges in a wide variety of strategic sectors, including human and animal nutrition, flavors and fragrances, life sciences, materials science, plus lubricants and technical fluids. AFYREN's competitive, plug-and-play, circular technology enables manufacturers to adopt sustainable solutions without modifying production processes. The company's first industrial plant, AFYREN NEOXY, a joint venture with Bpifrance's SPI fund, is based in the Grand-Est region of France, serving primarily the European market. AFYREN is also pursuing a project in Thailand with a global leader in the sugar industry and is building its presence in the Americas, based on existing distribution agreements. At the end of 2024, AFYREN employed 130 people across sites in Lyon, Clermont-Ferrand and Carling Saint-Avold. Committed to continuous innovation, the company invests 20% of its annual budget in R&D to further develop the range of sustainable solutions. AFYREN is listed on Euronext Growth® Paris since 2021 (ISIN code: FR0014005AC9, ticker: ALAFY). For more information, visit and follow us on LinkedIn View source version on Contacts AFYRENCommunicationCaroline Investor RelationsMark Reinhardinvest@ NewCapInvestor RelationsThéo Martin / Mathilde BohinTél : 01 44 71 94 94afyren@ NewCapMedia RelationsNicolas MerigeauTél : 01 44 71 94 98afyren@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
02-06-2025
- Business
- Business Wire
AFYREN: Availability of Preparatory Documents for the Combined General Meeting on June 17, 2025
CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering industrial customers bio-based, low-carbon products through its unique fermentation technology based on a circular model, today announced its Combined General Meeting will be held Tuesday, June 17, 2025, at 3:30 pm CEST, at the Company's office: Le Silex2 - City, 9 rue des Cuirassiers - 69003 Lyon. The preparatory documents for this General Meeting are available on the Company's website, in the Documentation / General Meetings section. The text of the resolutions was published in the meeting notice, published in the ' Bulletin des Annonces Légales Obligatoires ' (BALO) No. 57 of May 12, 2025. To submit their votes, shareholders may, in accordance with the procedures described in the meeting notice published in the BALO on May 12, 2025: attend the Meeting in person; vote by internet via the secure voting platform VOTACCESS; vote by mail; give proxy to the Chairman of the Meeting or to any other person of their choice. About AFYREN AFYREN is a French greentech company, founded in 2012, focused on providing innovative, sustainable solutions to reduce reliance on fossil-based resources. AFYREN's proprietary, nature-inspired fermentation technology valorizes local biomass from non-food agricultural co-products to produce 100% biobased, low-carbon carboxylic acids. The company's sustainable solutions address decarbonization challenges in a wide variety of strategic sectors, including human and animal nutrition, flavors and fragrances, life sciences, materials science, plus lubricants and technical fluids. AFYREN's competitive, plug-and-play, circular technology enables manufacturers to adopt sustainable solutions without modifying production processes. The company's first industrial plant, AFYREN NEOXY, a joint venture with Bpifrance's SPI fund, is based in the Grand-Est region of France, serving primarily the European market. AFYREN is also pursuing a project in Thailand with a global leader in the sugar industry and is building its presence in the Americas, based on existing distribution agreements. At the end of 2024, AFYREN employed 130 people across sites in Lyon, Clermont-Ferrand and Carling Saint-Avold. Committed to continuous innovation, the company invests 20% of its annual budget in R&D to further develop the range of sustainable solutions. AFYREN is listed on Euronext Growth ® Paris since 2021 (ISIN code: FR0014005AC9, ticker: ALAFY).
Yahoo
02-06-2025
- Business
- Yahoo
AFYREN: Availability of Preparatory Documents for the Combined General Meeting on June 17, 2025
E-voting available (VOTACCESS) from June 2, 2025, to June 16, 2025 (03:00 pm CEST) CLERMONT-FERRAND, France & LYON, France, June 02, 2025--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering industrial customers bio-based, low-carbon products through its unique fermentation technology based on a circular model, today announced its Combined General Meeting will be held Tuesday, June 17, 2025, at 3:30 pm CEST, at the Company's office: Le Silex2 - City, 9 rue des Cuirassiers - 69003 Lyon. The preparatory documents for this General Meeting are available on the Company's website, in the Documentation / General Meetings section. The text of the resolutions was published in the meeting notice, published in the "Bulletin des Annonces Légales Obligatoires" (BALO) No. 57 of May 12, 2025. To submit their votes, shareholders may, in accordance with the procedures described in the meeting notice published in the BALO on May 12, 2025: attend the Meeting in person; vote by internet via the secure voting platform VOTACCESS; vote by mail; give proxy to the Chairman of the Meeting or to any other person of their choice. About AFYREN AFYREN is a French greentech company, founded in 2012, focused on providing innovative, sustainable solutions to reduce reliance on fossil-based resources. AFYREN's proprietary, nature-inspired fermentation technology valorizes local biomass from non-food agricultural co-products to produce 100% biobased, low-carbon carboxylic acids. The company's sustainable solutions address decarbonization challenges in a wide variety of strategic sectors, including human and animal nutrition, flavors and fragrances, life sciences, materials science, plus lubricants and technical fluids. AFYREN's competitive, plug-and-play, circular technology enables manufacturers to adopt sustainable solutions without modifying production processes. The company's first industrial plant, AFYREN NEOXY, a joint venture with Bpifrance's SPI fund, is based in the Grand-Est region of France, serving primarily the European market. AFYREN is also pursuing a project in Thailand with a global leader in the sugar industry and is building its presence in the Americas, based on existing distribution agreements. At the end of 2024, AFYREN employed 130 people across sites in Lyon, Clermont-Ferrand and Carling Saint-Avold. Committed to continuous innovation, the company invests 20% of its annual budget in R&D to further develop the range of sustainable solutions. AFYREN is listed on Euronext Growth® Paris since 2021 (ISIN code: FR0014005AC9, ticker: ALAFY). For more information, visit and follow us on LinkedIn View source version on Contacts AFYRENCommunicationCaroline Investor RelationsMark Reinhardinvest@ NewCapInvestor RelationsThéo Martin / Mathilde BohinTél : 01 44 71 94 94afyren@ NewCapMedia RelationsNicolas MerigeauTél : 01 44 71 94 98afyren@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
